Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

The role of microRNAs in normal and malignant hematopoiesis.

Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J.

Eur J Haematol. 2010 Jan 1;84(1):1-16. doi: 10.1111/j.1600-0609.2009.01348.x. Epub 2009 Sep 10. Review.

PMID:
19744129
2.

MicroRNAs and haematology: small molecules, big function.

Lawrie CH.

Br J Haematol. 2007 Jun;137(6):503-12. Review.

PMID:
17539773
3.

MicroRNAs in normal and malignant hematopoiesis.

Garzon R, Croce CM.

Curr Opin Hematol. 2008 Jul;15(4):352-8. doi: 10.1097/MOH.0b013e328303e15d. Review.

PMID:
18536574
4.

MicroRNA function in cancer: oncogene or a tumor suppressor?

Shenouda SK, Alahari SK.

Cancer Metastasis Rev. 2009 Dec;28(3-4):369-78. doi: 10.1007/s10555-009-9188-5. Review.

PMID:
20012925
5.
6.

MicroRNAs in benign and malignant hematopoiesis.

Bhagavathi S, Czader M.

Arch Pathol Lab Med. 2010 Sep;134(9):1276-81. doi: 10.1043/2009-0178-RS.1. Review.

PMID:
20807046
7.

[Oncogenic and tumour suppressor microRNAs].

Finoux AL, Chartrand P.

Med Sci (Paris). 2008 Dec;24(12):1049-54. doi: 10.1051/medsci/200824121049. Review. French.

8.

miR signatures and the role of miRs in acute myeloid leukaemia.

Seca H, Almeida GM, GuimarĂ£es JE, Vasconcelos MH.

Eur J Cancer. 2010 Jun;46(9):1520-7. doi: 10.1016/j.ejca.2010.03.031. Epub 2010 Apr 21. Review.

PMID:
20413298
9.

Potential therapeutic applications of miRNA-based technology in hematological malignancies.

Barbarotto E, Calin GA.

Curr Pharm Des. 2008;14(21):2040-50. Review.

PMID:
18691114
10.

MicroRNAs: small but potent oncogenes or tumor suppressors.

Lee YS, Dutta A.

Curr Opin Investig Drugs. 2006 Jun;7(6):560-4. Review.

PMID:
16784027
11.

MiR-125 in normal and malignant hematopoiesis.

Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S.

Leukemia. 2012 Sep;26(9):2011-8. doi: 10.1038/leu.2012.90. Epub 2012 Mar 29. Review.

PMID:
22456625
12.

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.

Hummel R, Hussey DJ, Haier J.

Eur J Cancer. 2010 Jan;46(2):298-311. doi: 10.1016/j.ejca.2009.10.027. Epub 2009 Nov 28. Review.

PMID:
19948396
13.

MicroRNA expression and function in cancer.

Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM.

Trends Mol Med. 2006 Dec;12(12):580-7. Epub 2006 Oct 30. Review.

PMID:
17071139
14.

Role of microRNAs in hematological malignancies.

Fatica A, Bozzoni I.

Expert Rev Hematol. 2009 Aug;2(4):415-23. doi: 10.1586/ehm.09.32. Review.

PMID:
21082946
15.

microRNAs as oncogenes and tumor suppressors.

Zhang B, Pan X, Cobb GP, Anderson TA.

Dev Biol. 2007 Feb 1;302(1):1-12. Epub 2006 Aug 16. Review.

16.

MicroRNAs: emerging key regulators of hematopoiesis.

Havelange V, Garzon R.

Am J Hematol. 2010 Dec;85(12):935-42. doi: 10.1002/ajh.21863. Review.

17.

[Roles of microRNAs in hematopoietic cell differentiation and the related tumors].

Yang GH, Wang F, Zhang JW.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Jun;29(3):425-9. Review. Chinese.

18.

The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.

Calin GA, Pekarsky Y, Croce CM.

Best Pract Res Clin Haematol. 2007 Sep;20(3):425-37. Review.

PMID:
17707831
19.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

20.

MicroRNAs in normal and cancer cells: a new class of gene expression regulators.

Bagnyukova TV, Pogribny IP, Chekhun VF.

Exp Oncol. 2006 Dec;28(4):263-9. Review.

PMID:
17285108

Supplemental Content

Support Center